Article
Molecular Biomarkers of Sessile Serrated Adenoma/Polyps.
Clinical and translational gastroenterology - 1 Dec 2019
Kanth Priyanka, Boylan Katherine E, Bronner Mary P, Boucher Kenneth M, Hazel Mark W, Yao Ruoxin, Pop Stelian, Bernard Philip S, Delker Don A
Abstract excerpt
OBJECTIVES: Sessile serrated adenoma/polyps (SSA/Ps) contribute up to 30% of all colon cancers. There is considerable histological overlap between SSA/Ps and hyperplastic polyps. Inadequate consensus exists among pathologists, and no molecular biomarkers exist to differentiate these lesions with high accuracy. Lack of reliable diagnosis adversely affects clinical care. We previously defined a novel 7-gene panel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
